PharmaCyte Biotech, Inc. Business Operations Contracts & Agreements
9 Contracts & Agreements
- Advisory Agreements (1 contract)
- Collaboration Agreements (1)
- Cooperation Agreements (1)
- MOUs (2)
- Services Agreements (1)
- Settlement Agreements (1)
- Termination Agreements (2)
- Form of Collaboration Agreement (Filed With SEC on November 16, 2023)
- Cooperation Agreement dated August 15, 2022, by and between PharmaCyte Biotech, Inc. and Iroquois Master Fund Ltd. and its affiliates (Filed With SEC on August 16, 2022)
- Mutual Termination Agreement dated January 26, 2018, by and between PharmaCyte Biotech, Inc. and Chardan Capital Markets, LLC (Filed With SEC on February 22, 2018)
- Financial Advisory, Offering and At-the-Market Offering Engagement Letter dated February 22, 2018, by and between PharmaCyte Biotech, Inc. and Aeon Capital, Inc (Filed With SEC on February 22, 2018)
- BINDING MEMORANDUM OF UNDERSTANDING (Filed With SEC on July 29, 2016)
- SETTLEMENT AGREEMENT (Filed With SEC on September 25, 2014)
- MEMORANDUM OF UNDERSTANDING (Filed With SEC on August 4, 2014)
- MASTER SERVICES AGREEMENT (Filed With SEC on August 4, 2014)
- MUTUAL TERMINATION AND RELEASE AGREEMENT (Filed With SEC on May 29, 2014)
